Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study

Fluorescein angiography (FA) is an important tool for the diagnosis and management of diabetic retinopathy. However, the safety of fluorescein sodium on renal functions is not fully understood. One hundred type 2 diabetes patients, within the Ophthalmology Outpatient Clinic at Alexandria Main Univer...

Full description

Bibliographic Details
Main Authors: Waleed H Almalki, Ashraf Nabiel Abdalla, Ahmed F Elkeraie, Ahmed M Abdelhadi, Mahmoud Elrggal, Mohamed E Elrggal
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=491;epage=498;aulast=Almalki
id doaj-1a449f8bfb5d44e7b5bfd57a2393d6b4
record_format Article
spelling doaj-1a449f8bfb5d44e7b5bfd57a2393d6b42020-11-25T01:32:40ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422017-01-0128349149810.4103/1319-2442.206444Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot studyWaleed H AlmalkiAshraf Nabiel AbdallaAhmed F ElkeraieAhmed M AbdelhadiMahmoud ElrggalMohamed E ElrggalFluorescein angiography (FA) is an important tool for the diagnosis and management of diabetic retinopathy. However, the safety of fluorescein sodium on renal functions is not fully understood. One hundred type 2 diabetes patients, within the Ophthalmology Outpatient Clinic at Alexandria Main University Hospital, Egypt, were enrolled in this prospective observational study to determine the safety of FA on renal function. Serum creatinine and cystatin C were measured pre- and 2 days post-FA. Urinary neutrophil gelatinase-associated lipocalin (uNGAL) was measured pre- and 4 hours post-FA. Renal injury was defined as a 25% increase in serum creatinine, cystatin C, or uNGAL. The study included 71 females and 29 males, with a mean age of 55.73 ± 7.29 years. Baseline serum cystatin C and uNGAL were 0.89 ± 0.34 mg/L and 21.7 ± 2.39 ng/mL, respectively. Serum cystatin C and uNGAL significantly increased after FA to 0.95 ± 0.36 and 27 ± 2.81, respectively (P <0.001). Eleven patients (11%) experienced more than a 25% rise in serum cystatin C from baseline, whereas 40 patients (40%) experienced more than a 25% increase in uNGAL levels after FA. However, the mean serum creatinine level did not change significantly after FA (P = 0.061). Only one patient experienced more than a 25% rise in serum creatinine from baseline. FA showed a significant increase in early sensitive acute kidney injury biomarkers (as serum cystatin C and uNGAL) in substantial number of patients, suggesting but still not proving, a potential harmful effect of FA on kidney functions. These findings were not demonstrated using ordinary serum creatinine.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=491;epage=498;aulast=Almalki
collection DOAJ
language English
format Article
sources DOAJ
author Waleed H Almalki
Ashraf Nabiel Abdalla
Ahmed F Elkeraie
Ahmed M Abdelhadi
Mahmoud Elrggal
Mohamed E Elrggal
spellingShingle Waleed H Almalki
Ashraf Nabiel Abdalla
Ahmed F Elkeraie
Ahmed M Abdelhadi
Mahmoud Elrggal
Mohamed E Elrggal
Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study
Saudi Journal of Kidney Diseases and Transplantation
author_facet Waleed H Almalki
Ashraf Nabiel Abdalla
Ahmed F Elkeraie
Ahmed M Abdelhadi
Mahmoud Elrggal
Mohamed E Elrggal
author_sort Waleed H Almalki
title Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study
title_short Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study
title_full Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study
title_fullStr Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study
title_full_unstemmed Effect of fluorescein angiography on renal functions in type 2 diabetes patients: A pilot study
title_sort effect of fluorescein angiography on renal functions in type 2 diabetes patients: a pilot study
publisher Wolters Kluwer Medknow Publications
series Saudi Journal of Kidney Diseases and Transplantation
issn 1319-2442
publishDate 2017-01-01
description Fluorescein angiography (FA) is an important tool for the diagnosis and management of diabetic retinopathy. However, the safety of fluorescein sodium on renal functions is not fully understood. One hundred type 2 diabetes patients, within the Ophthalmology Outpatient Clinic at Alexandria Main University Hospital, Egypt, were enrolled in this prospective observational study to determine the safety of FA on renal function. Serum creatinine and cystatin C were measured pre- and 2 days post-FA. Urinary neutrophil gelatinase-associated lipocalin (uNGAL) was measured pre- and 4 hours post-FA. Renal injury was defined as a 25% increase in serum creatinine, cystatin C, or uNGAL. The study included 71 females and 29 males, with a mean age of 55.73 ± 7.29 years. Baseline serum cystatin C and uNGAL were 0.89 ± 0.34 mg/L and 21.7 ± 2.39 ng/mL, respectively. Serum cystatin C and uNGAL significantly increased after FA to 0.95 ± 0.36 and 27 ± 2.81, respectively (P <0.001). Eleven patients (11%) experienced more than a 25% rise in serum cystatin C from baseline, whereas 40 patients (40%) experienced more than a 25% increase in uNGAL levels after FA. However, the mean serum creatinine level did not change significantly after FA (P = 0.061). Only one patient experienced more than a 25% rise in serum creatinine from baseline. FA showed a significant increase in early sensitive acute kidney injury biomarkers (as serum cystatin C and uNGAL) in substantial number of patients, suggesting but still not proving, a potential harmful effect of FA on kidney functions. These findings were not demonstrated using ordinary serum creatinine.
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2017;volume=28;issue=3;spage=491;epage=498;aulast=Almalki
work_keys_str_mv AT waleedhalmalki effectoffluoresceinangiographyonrenalfunctionsintype2diabetespatientsapilotstudy
AT ashrafnabielabdalla effectoffluoresceinangiographyonrenalfunctionsintype2diabetespatientsapilotstudy
AT ahmedfelkeraie effectoffluoresceinangiographyonrenalfunctionsintype2diabetespatientsapilotstudy
AT ahmedmabdelhadi effectoffluoresceinangiographyonrenalfunctionsintype2diabetespatientsapilotstudy
AT mahmoudelrggal effectoffluoresceinangiographyonrenalfunctionsintype2diabetespatientsapilotstudy
AT mohamedeelrggal effectoffluoresceinangiographyonrenalfunctionsintype2diabetespatientsapilotstudy
_version_ 1725080583656177664